囊性纤维化胸腔积液的MRI评分不需要静脉注射对比剂
本研究纳入75例囊性纤维化患者,采用盲法多读者设计比较增强与非增强MRI序列对胸膜病变的评估价值。结果显示无增强脂肪饱和T1加权序列与增强T1加权序列的总胸膜病变评分高度一致,提示胸膜评估无需静脉对比剂。
要点
- 无增强脂肪饱和T1加权序列与增强T1加权序列在总胸膜病变评分上高度一致。
- T2FS倾向于高估、T1UE倾向于低估肺叶及总胸膜病变评分。
- 囊性纤维化患者胸膜病变的MRI评估可不依赖静脉对比剂。
核心结论
- 无对比剂脂肪饱和T1加权序列对囊性纤维化相关胸膜病变的诊断价值与增强T1加权序列相当,胸膜评估不需要静脉对比剂。
研究设计与样本
- 盲法多读者研究,纳入75例囊性纤维化患者,行形态功能胸部MRI(含增强与非增强序列),由两名盲法独立读者按胸部MRI评分系统对每个肺叶及全胸膜评分,分歧由胸部放射科医师裁定。
关键影像表现/征象
- 评估序列包括3D梯度回波T1加权序列(无增强脂肪饱和T1UEFS、无增强无脂肪饱和T1UE、增强脂肪饱和T1CEFS)及高分辨率脂肪饱和T2加权序列T2FS。
- 所有序列在所有肺叶的读者间一致性均良好。
- T2FS倾向于高估肺叶及总胸膜病变评分,T1UE倾向于低估。
诊断标准与关键数值
- 所有无增强MRI序列与T1CEFS在总胸膜病变评分上均呈强相关,其中T1UEFS一致性最高。
- 采用胸部MRI评分系统对每个肺叶和全胸膜进行半定量评分(肺叶/总胸膜病变评分)。
临床应用与阅片要点
- 无增强脂肪饱和T1加权序列可用于评估囊性纤维化患者的胸膜炎症和增厚。
- 阅片时注意T2FS可能高估、T1UE可能低估胸膜病变评分。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Cystic fibrosis (CF) leads to severe lung disease requiring regular monitoring. The morpho-functional chest MRI score enables reproducible semi-quantitative assessment of CF-related pulmonary and pleural changes, but the optimal sequences for pleural evaluation and the need for intravenous contrast media remain uncertain. This study aims to investigate the usability and agreement of different unenhanced and contrast-enhanced MRI sequences in assessing CF-related pleural findings using a blinded multi-reader study design.
MATERIALS AND METHODS: This study included 75 people with CF (pwCF), who underwent morpho-functional chest MRI comprising contrast-enhanced and unenhanced sequences. Three 3D gradient echo T1-weighted sequences (unenhanced with (T1UEFS) and without fat saturation (T1UE), contrast-enhanced with fat saturation (T1CEFS)) and a high-resolution T2-weighted sequence with fat saturation (T2FS) were evaluated by two blinded independent readers applying the chest MRI scoring system for each individual lung lobe and the entire pleura (lobar/total pleural findings score). In case of deviations, a thoracic radiologist adjudicated. Statistical analyses included Spearman's correlation, Kruskal-Wallis test, and intraclass correlation coefficients.
RESULTS: Interreader agreement was consistently good for all sequences and for all pulmonary lobes. While all unenhanced MRI sequences showed strong correlation with T1CEFS regarding the total pleural findings score, T1UEFS showed the highest agreement. T2FS tended to overestimate, and T1UE tended to underestimate lobar and total pleural findings scores.
CONCLUSIONS: Contrast-enhanced T1-weighted imaging is standard for assessing CF-related pleural inflammation and thickening. Our findings show that contrast agent-free fat-saturated T1-weighted sequences provide equivalent diagnostic value, indicating contrast media are not required for pleural assessment in pwCF.
KEY POINTS: Question It is unclear which MRI sequence is best for assessing signs of pleurisy in pwCF and whether intravenous contrast media is required. Findings Pleural inflammation and thickening can be diagnosed just as precisely with an unenhanced fat-saturated T1-weighted sequence as with a contrast-enhanced T1-weighted sequence. Clinical relevance The assessment of pleural findings in MRI is not dependent on the use of intravenous contrast media. For pwCF, this paves the way for future routine MRI monitoring without contrast agents, thereby streamlining imaging protocols and reducing patient burden.
引用
- Schobert IT, Posch H, Steffen IG, et al. MRI scoring of pleural findings in cystic fibrosis does not require intravenous contrast media. Eur Radiol. 2025. PMID: 41436642. doi:10.1007/s00330-025-12209-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。